UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000022076
Receipt No. R000025424
Scientific Title A phase II, open label, single arm study to assess the efficacy of AZD9291 in patients with locally advanced/metastatic non-small cell lung cancer who are harboring T790M mutation detected by liquid biopsy and whose disease has progressed with previous epidermal growth factor receptor tyrosine kinase inhibitor therapy(WJOG8815L)
Date of disclosure of the study information 2016/04/26
Last modified on 2020/04/29 09:57:16

No. Disposal Last modified on Item of update
1 Insert 2016/04/26 17:20:31
2 Update 2016/10/25 09:34:18 Recruitment status
Anticipated trial start date
3 Update 2016/10/25 09:39:08 Key inclusion criteria
Key inclusion criteria
4 Update 2017/10/30 16:10:21 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2017/10/31 04:25:13 Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2018/06/04 09:12:24 Recruitment status
7 Update 2018/10/29 11:20:50 Date trial data considered complete
Date analysis concluded
8 Update 2020/04/29 09:57:16 Recruitment status
Date of IRB


Contact us.